arrow
I

Ingrid J.G. Burvenich

olivia newton-john cancer research institute
H指数:17
被引数:1,205

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

DNA-Dependent Protein Kinase Inhibitor Peposertib Enhances Efficacy of 177Lu-Based Radioimmunotherapy in Preclinical Models of Prostate and Renal Cell Carcinoma

DNA依赖性蛋白激酶抑制剂Peposertib增强了基于177Lu的放射性免疫疗法在前列腺癌和肾细胞癌的预临床模型中的疗效

2025-01-300
PRE
Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with 89Zr-labelled CI-8993 (Jul 26, 10.1007/s00259-024-06854-z, 2024)
2024-08-260
OAAI
Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2

靶向ASCT2的新型吡咯并苯并二氮杂 (PBD) 抗体药物缀合物的临床前放射性标记,体内生物分布和正电子发射断层扫描

2023-07-015
OAAI
Bromodomain and extraterminal protein-targeted probe enables tumour visualisation in vivo using positron emission tomography

溴结构域和末端外蛋白靶向探针可使用正电子发射断层扫描在体内可视化肿瘤

2023-01-010
PRE
A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancers
2022-04-1119
PRE
Radiolabelling and preclinical characterization of 89Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfa
2021-02-1919
PREAI
ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer

ELOVL5是前列腺癌中关键且可靶向的脂肪酸延长酶

2021-02-0550
OA
Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to Protect prostate tumor cells from ferroptosis

人类DECR1是一种雄激素抑制的生存因子,调节PUFA氧化以保护前列腺肿瘤细胞免受铁死亡

2020-07-20124
OA